vs

Side-by-side financial comparison of FIRST COMMUNITY BANKSHARES INC (FCBC) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.

RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $43.8M, roughly 1.3× FIRST COMMUNITY BANKSHARES INC). FIRST COMMUNITY BANKSHARES INC runs the higher net margin — 28.5% vs -83.0%, a 111.4% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs 5.1%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 3.5%).

First Community Bankshares, Inc. is a $2.43 billion bank holding company and the parent company of First Community Bank of Bluefield, Virginia, in the United States. As of 2012 First Community Bank had 45 locations in Virginia, West Virginia, and North Carolina, and two locations operating as Peoples Community Bank in Tennessee. As of April 21, 2023, First Community had $3.6 billion in assets.

Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.

FCBC vs RYTM — Head-to-Head

Bigger by revenue
RYTM
RYTM
1.3× larger
RYTM
$57.3M
$43.8M
FCBC
Growing faster (revenue YoY)
RYTM
RYTM
+31.8% gap
RYTM
36.9%
5.1%
FCBC
Higher net margin
FCBC
FCBC
111.4% more per $
FCBC
28.5%
-83.0%
RYTM
Faster 2-yr revenue CAGR
RYTM
RYTM
Annualised
RYTM
48.5%
3.5%
FCBC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FCBC
FCBC
RYTM
RYTM
Revenue
$43.8M
$57.3M
Net Profit
$12.5M
$-47.5M
Gross Margin
91.6%
Operating Margin
36.8%
-82.2%
Net Margin
28.5%
-83.0%
Revenue YoY
5.1%
36.9%
Net Profit YoY
-4.4%
-9.6%
EPS (diluted)
$0.67
$-0.73

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FCBC
FCBC
RYTM
RYTM
Q4 25
$43.8M
$57.3M
Q3 25
$42.2M
$51.3M
Q2 25
$41.0M
$48.5M
Q1 25
$40.5M
$32.7M
Q4 24
$41.7M
$41.8M
Q3 24
$42.0M
$33.3M
Q2 24
$41.3M
$29.1M
Q1 24
$40.9M
$26.0M
Net Profit
FCBC
FCBC
RYTM
RYTM
Q4 25
$12.5M
$-47.5M
Q3 25
$12.3M
$-52.9M
Q2 25
$12.2M
$-46.6M
Q1 25
$11.8M
$-49.5M
Q4 24
$13.0M
$-43.3M
Q3 24
$13.0M
$-43.6M
Q2 24
$12.7M
$-32.3M
Q1 24
$12.8M
$-141.4M
Gross Margin
FCBC
FCBC
RYTM
RYTM
Q4 25
91.6%
Q3 25
89.3%
Q2 25
88.6%
Q1 25
88.8%
Q4 24
90.9%
Q3 24
88.5%
Q2 24
89.9%
Q1 24
89.2%
Operating Margin
FCBC
FCBC
RYTM
RYTM
Q4 25
36.8%
-82.2%
Q3 25
37.7%
-102.6%
Q2 25
38.6%
-93.4%
Q1 25
37.7%
-143.7%
Q4 24
39.6%
-98.6%
Q3 24
39.3%
-132.0%
Q2 24
39.3%
-139.2%
Q1 24
40.3%
-538.7%
Net Margin
FCBC
FCBC
RYTM
RYTM
Q4 25
28.5%
-83.0%
Q3 25
29.1%
-103.1%
Q2 25
29.9%
-96.1%
Q1 25
29.2%
-151.4%
Q4 24
31.3%
-103.6%
Q3 24
31.0%
-131.2%
Q2 24
30.8%
-110.9%
Q1 24
31.4%
-544.4%
EPS (diluted)
FCBC
FCBC
RYTM
RYTM
Q4 25
$0.67
$-0.73
Q3 25
$0.67
$-0.82
Q2 25
$0.67
$-0.75
Q1 25
$0.64
$-0.81
Q4 24
$0.67
$-0.71
Q3 24
$0.71
$-0.73
Q2 24
$0.71
$-0.55
Q1 24
$0.71
$-2.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FCBC
FCBC
RYTM
RYTM
Cash + ST InvestmentsLiquidity on hand
$388.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$500.5M
$139.1M
Total Assets
$3.3B
$480.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FCBC
FCBC
RYTM
RYTM
Q4 25
$388.9M
Q3 25
$416.1M
Q2 25
$291.0M
Q1 25
$314.5M
Q4 24
$320.6M
Q3 24
$298.4M
Q2 24
$319.1M
Q1 24
$201.2M
Total Debt
FCBC
FCBC
RYTM
RYTM
Q4 25
Q3 25
$0
Q2 25
$0
Q1 25
$0
Q4 24
$0
Q3 24
$0
Q2 24
$0
Q1 24
$0
Stockholders' Equity
FCBC
FCBC
RYTM
RYTM
Q4 25
$500.5M
$139.1M
Q3 25
$510.7M
$148.8M
Q2 25
$502.8M
$-11.9M
Q1 25
$496.4M
$18.9M
Q4 24
$526.4M
$21.7M
Q3 24
$520.7M
$11.2M
Q2 24
$508.9M
$39.3M
Q1 24
$506.9M
$61.6M
Total Assets
FCBC
FCBC
RYTM
RYTM
Q4 25
$3.3B
$480.2M
Q3 25
$3.2B
$506.9M
Q2 25
$3.2B
$372.7M
Q1 25
$3.2B
$386.7M
Q4 24
$3.3B
$392.3M
Q3 24
$3.2B
$363.6M
Q2 24
$3.2B
$381.8M
Q1 24
$3.2B
$258.7M
Debt / Equity
FCBC
FCBC
RYTM
RYTM
Q4 25
Q3 25
0.00×
Q2 25
0.00×
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FCBC
FCBC
RYTM
RYTM
Operating Cash FlowLast quarter
$62.7M
$-25.4M
Free Cash FlowOCF − Capex
$60.0M
FCF MarginFCF / Revenue
137.0%
Capex IntensityCapex / Revenue
6.3%
Cash ConversionOCF / Net Profit
5.03×
TTM Free Cash FlowTrailing 4 quarters
$100.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FCBC
FCBC
RYTM
RYTM
Q4 25
$62.7M
$-25.4M
Q3 25
$18.9M
$-26.6M
Q2 25
$10.2M
$-23.3M
Q1 25
$13.2M
$-40.4M
Q4 24
$57.7M
$-18.8M
Q3 24
$11.4M
$-25.2M
Q2 24
$14.5M
$-29.1M
Q1 24
$16.9M
$-40.7M
Free Cash Flow
FCBC
FCBC
RYTM
RYTM
Q4 25
$60.0M
Q3 25
$18.5M
Q2 25
$10.0M
Q1 25
$12.1M
Q4 24
$54.9M
Q3 24
$10.9M
Q2 24
$14.1M
Q1 24
$15.2M
FCF Margin
FCBC
FCBC
RYTM
RYTM
Q4 25
137.0%
Q3 25
43.9%
Q2 25
24.3%
Q1 25
29.8%
Q4 24
131.8%
Q3 24
26.0%
Q2 24
34.1%
Q1 24
37.1%
Capex Intensity
FCBC
FCBC
RYTM
RYTM
Q4 25
6.3%
Q3 25
1.0%
Q2 25
0.6%
Q1 25
2.8%
Q4 24
6.7%
Q3 24
1.2%
Q2 24
0.9%
Q1 24
4.4%
Cash Conversion
FCBC
FCBC
RYTM
RYTM
Q4 25
5.03×
Q3 25
1.54×
Q2 25
0.83×
Q1 25
1.12×
Q4 24
4.43×
Q3 24
0.88×
Q2 24
1.14×
Q1 24
1.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons